{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T07:18:03Z","timestamp":1720423083019},"reference-count":67,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2014.00042","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T09:13:56Z","timestamp":1415092436000},"source":"Crossref","is-referenced-by-count":5,"title":["Hemolytic Uremic Syndrome: Toxins, Vessels, and Inflammation"],"prefix":"10.3389","volume":"1","author":[{"given":"Victoria","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Trachtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.pcl.2013.08.007","article-title":"HUS and TTP in children","volume":"60","author":"Trachtman","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0140-6736(05)71144-2","article-title":"Shiga-toxin-producing Escherichia coli and hemolytic uremic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","article-title":"Investigators of the HUS-SYNSORB Pk\u00c2\u00ae multicenter clinical trial. Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial","volume":"290","author":"Trachtman","year":"2003","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","article-title":"Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany","volume":"365","author":"Frank","year":"2011","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: causes and short-term course","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/600302","article-title":"Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006","volume":"49","author":"Hedican","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/INF.0b013e3182191c58","article-title":"Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America","volume":"30","author":"Banerjee","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.V102281","article-title":"Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian registry of familial and recurrent hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura","volume":"10","author":"Noris","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"European working party on complement genetics in renal diseases. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1681\/ASN.2013080886","article-title":"Phenotypic expansion of DGKE-associated diseases","volume":"25","author":"Westland","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-0031-1300951","article-title":"Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13","volume":"38","author":"Chapman","year":"2012","journal-title":"Semin Thromb Hemost"},{"issue":"6 Pt 1","key":"B17","first-page":"G1349","article-title":"Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium","volume":"273","author":"Philpott","year":"1997","journal-title":"Am J Physiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1189\/jlb.0709475","article-title":"Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration","volume":"88","author":"Brigotti","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/INF.0b013e3182074d22","article-title":"Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome","volume":"30","author":"Brigotti","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrneph.2012.196","article-title":"Renal and neurological involvement in typical Shiga toxin-associated HUS","volume":"8","author":"Trachtman","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.toxicon.2009.11.021","article-title":"Endocytosis and retrograde transport of Shiga toxin","volume":"56","author":"Sandvig","year":"2010","journal-title":"Toxicon"},{"key":"B22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1215930","article-title":"Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis","volume":"335","author":"Mukhopadhyay","year":"2012","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MNH.0b013e328354a62e","article-title":"Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics","volume":"21","author":"Petruzziello-Pellegrini","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","article-title":"Thrombotic microangiopathy and associated renal disorders","volume":"27","author":"Barbour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/infdis\/jit268","article-title":"Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome","volume":"208","author":"Page","year":"2013","journal-title":"J Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00467-010-1555-5","article-title":"Genetics and complement in atypical HUS","volume":"25","author":"Kavanagh","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-med-072211-110606","article-title":"Defective complement inhibitory function predisposes to renal disease","volume":"64","author":"Java","year":"2013","journal-title":"Annu Rev Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1128\/IAI.70.9.5316-5318.2002","article-title":"Shiga toxin 2 induces macrophage-granulocyte colonies from human bone marrow and cord blood stem cells","volume":"70","author":"Chiyoda","year":"2002","journal-title":"Infect Immun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1189\/jlb.0505251","article-title":"Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome","volume":"78","author":"Fern\u00c3\u00a1ndez","year":"2005","journal-title":"J Leukoc Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2249.2006.03155.x","article-title":"Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia","volume":"146","author":"Fernandez","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/00006454-200007000-00012","article-title":"Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome","volume":"19","author":"Buteau","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1203\/00006450-200212000-00019","article-title":"Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome","volume":"52","author":"Proulx","year":"2002","journal-title":"Pediatr Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1128\/IAI.01663-06","article-title":"Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome","volume":"75","author":"Keepers","year":"2007","journal-title":"Infect Immun"},{"issue":"3","key":"B34","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ajpath.2011.11.011","article-title":"Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome","volume":"180","author":"Ramos","year":"2012","journal-title":"Am J Pathol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1182\/blood-2006-06-026997","article-title":"Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1172\/JCI57313","article-title":"The CXCR4\/CXCR7\/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice","volume":"122","author":"Petruzziello-Pellegrini","year":"2012","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00467-011-2014-7","article-title":"Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome","volume":"27","author":"Vall\u00c3\u00a9s","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s10875-011-9646-z","article-title":"Cytokine production is altered in monocytes from children with hemolytic uremic syndrome","volume":"32","author":"Fern\u00c3\u00a1ndez","year":"2012","journal-title":"J Clin Immunol"},{"key":"B39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V88.1.174.174","article-title":"Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release","volume":"88","author":"van Setten","year":"1996","journal-title":"Blood"},{"key":"B40","first-page":"202","article-title":"Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome","volume":"92","author":"Van de Kar","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"B41","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s004670050712","article-title":"Circulating inflammatory cytokine levels in hemolytic uremic syndrome","volume":"13","author":"Litalien","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jneuroim.2008.02.012","article-title":"Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy","volume":"196","author":"Shiraishi","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000187063","article-title":"Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome","volume":"62","author":"Robson","year":"1992","journal-title":"Nephron"},{"key":"B44","first-page":"126","article-title":"Renal histopathology in the hemolytic-uremic syndrome following shigellosis","volume":"21","author":"Koster","year":"1984","journal-title":"Clin Nephrol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","article-title":"Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome","volume":"117","author":"St\u00c3\u00a5hl","year":"2011","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1681\/ASN.2013050450","article-title":"Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement","volume":"25","author":"Locatelli","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"B50","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archpediatrics.2011.152","article-title":"Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome","volume":"165","author":"Hickey","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s004670050187","article-title":"Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not anuria","volume":"10","author":"Schulman","year":"1996","journal-title":"Pediatr Nephrol"},{"issue":"26","key":"B52","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-British associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"B53","author":"European Centre for Disease Prevention and Control","year":"2011","journal-title":"Shiga Toxin-Producing E coli (STEC): Update on Outbreak in the EU"},{"key":"B54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","article-title":"Outbreak of Escherichia coli O104:H4 haemolytic uremic syndrome in France: outcome with eculizumab","volume":"29","author":"Delmas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B55","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/cid\/cis531","article-title":"An outbreak of Shiga-toxin producing E. coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children","volume":"55","author":"Loos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.ajkd.2014.01.434","article-title":"Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases","volume":"64","author":"Ardissino","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1769","DOI":"10.1542\/peds.2013-2921","article-title":"Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment","volume":"133","author":"Belingheri","year":"2014","journal-title":"Pediatrics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.molimm.2013.05.224","article-title":"Complement therapy in atypical haemolytic uremic syndrome (aHUS)","volume":"56","author":"Wong","year":"2013","journal-title":"Mol Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1248\/bpb.29.1470","article-title":"Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: suppression of p38, JNK and NF-kappaB p65 as potential targets","volume":"29","author":"Moon","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"B61","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1086\/427188","article-title":"Inhibition of p38 mitogen-activated protein kinase ameliorates cytokine up-regulated shigatoxin-1 toxicity in human brain microvascular endothelial cells","volume":"191","author":"Stricklett","year":"2005","journal-title":"J Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.49","article-title":"The etiology of glomerulonephritis: roles of infection and autoimmunity","author":"Couser","year":"2014","journal-title":"Kidney Int"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","article-title":"Long-term outcomes of Shiga toxin hemolytic uremic syndrome","volume":"28","author":"Spinale","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","article-title":"Working party from the renal association, the British committee for standards in haematology and the British transplantation society. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom","volume":"148","author":"Taylor","year":"2010","journal-title":"Br J Haematol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00467-008-0799-9","article-title":"Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome","volume":"23","author":"Oakes","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00467-006-0283-3","article-title":"Prognostic significance of microalbuminuria in postdiarrheal hemolytic uremic syndrome","volume":"22","author":"Lou-Meda","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"}],"container-title":["Frontiers in Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T04:18:30Z","timestamp":1650514710000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2014.00042\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":67,"URL":"https:\/\/doi.org\/10.3389\/fmed.2014.00042","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,4]]}}}